Associated Papers
An intermediate-effect size variant in UMOD confers risk for chronic kidney disease.
Olinger E et al.
Proceedings of the National Academy of Sciences of the United States of America, 2022
35947615 (PubMed )
Supplement: pnas.2114734119.sapp.pdf
UMOD-related autosomal dominant tubulointerstitial kidney disease: An unfavourable novel mutation.
Viaño Nogueira P et al.
Nefrologia, 2021
Uromodulin: from physiology to rare and complex kidney disorders.
Devuyst O et al.
Nature Reviews. Nephrology, 2017
UMOD-related autosomal dominant tubulointerstitial kidney disease: an unfavourable novel mutation.
Viaño Nogueira P et al.
Nefrologia, 0
Select a paper to view details